Is HFE involved in increased hepcidin expression and hypoferremia in inflammation and anemia of chronic disease?

Hepatology

Volumn 41, Issue 4, 2005, Pages 936-938

  Milward, Elizabeth A ^a   Trinder, Deborah ^b   Wilcox, Chantelle E J ^a   Britton, Robert S ^c   Ramm, Grant A ^d   Olynyk, John K ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEPCIDIN; INTERLEUKIN 6; IRON; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ANEMIA; ANEMIA OF CHRONIC DISEASE; ANIMAL MODEL; CHRONIC DISEASE; ERYTHROCYTE; HEMOCHROMATOSIS; HUMAN; INFECTION; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON STORAGE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 16244374915     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20652     Document Type: Note

References (19)

1. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-7810.
2. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;98:8780-8785.
3. Means RT Jr. The anaemia of infection. Bailliere's Best Practice Clin Haematol 2000;13:151-162.
4. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 2002;16:87-96.
5. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002;100:3776-3781.
6. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044.
7. Roy CN, Custodio AO, de Graaf J, Schneider S, Akpan I, Montross LK, et al. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat Genet 2004;36:481-485.
8. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004;11:251-254.
9. Robson KJ. Hepcidin and its role in iron absorption. Gut 2004;53:617-619.
10. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-7819.
11. Mazur A, Feillet-Coudray C, Romier B, Bayle D, Gueux E, Ruivard M, et al. Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 2003;52:1229-1231.
12. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99:4596-4601.
13. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34:97-101.
14. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-22.
15. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003;361:669-673.
16. Ahmad KA, Ahmann JR, Migas MC, Waheed A, Britton RS, Bacon BR, et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 2002;29:361-366.
17. Muckenthaler M, Roy CN, Custodio AO, Minana B, de Graaf J, Montross LK, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 2003;34:102-107.
18. Frazer DM, Wilkins SJ, Millard KN, McKie AT, Vulpe CD, Anderson GJ. Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE. Br J Haematol 2004;126:434-436.
19. Lee P, Peng H, Gelbart T, Beutler E. The IL-6- and lipopolysaccharide- induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 2004;101:9263-9265.